NGS Panel for Acute Myeloid Leukemia

OGT’s RNA-based SureSeq Myeloid Fusion Panel is a new-generation sequencing tool for identifying fusion genes implicated in acute myeloid leukemia. The company claims the new panel addresses the latest research recommendations, identifying over 30 key disease-associated fusions in AML in a single assay. The panel is compatible with OGT’s existing end-to-end Universal NGS Complete Workflow Solution and software to minimize hands-on time and provide analysis without the need for additional bioinformatics resources. The launch expands the company’s portfolio to offer more NGS solutions for hematological malignancies and solid tumor cancer research.


Previous articleViral Takeover of Cells Captured with Super-Resolution Microscopy
Next articleDigital Liquid Flow Sensor